Tech company IBM (IBM) is working with Oracle (ORCL) to bring its watsonx AI tools to Oracle Cloud Infrastructure (OCI). This move strengthens their long-standing partnership and aims to improve how businesses use AI across their entire operations. Starting in July, IBM’s watsonx Orchestrate AI agents will be available on OCI. These agents are designed to help businesses manage complex workflows that involve both Oracle and non-Oracle apps and data sources by making everything work together more smoothly.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The AI agents from IBM will work with Oracle’s existing AI tools, like the Oracle AI Agent Studio and OCI Generative AI Agents. This expands what companies can do with Oracle Fusion Applications by adding more ways to use AI in different apps and systems. The first tasks these AI agents will focus on are in human resources. The agents will run on OCI using Red Hat OpenShift and will be available in public, government, sovereign, and Oracle Alloy cloud regions. They can also run on-premises or in other cloud setups to meet privacy and regulatory needs.
Oracle also plans to offer IBM’s Granite AI models through OCI Data Science later this year. These open-source models will be easier to access through OCI’s AI Quick Actions and will be available as cached models. Additionally, IBM will launch its Envizi ESG Suite—a tool for tracking environmental and social data—on OCI in Saudi Arabia within the next 12 months. As a result, IBM’s watsonx.ai is now certified to run on OCI, which gives businesses a reliable platform to build, run, and manage AI apps using tools, APIs, models, and runtimes.
What Is the Target Price for IBM?
Turning to Wall Street, analysts have a Moderate Buy consensus rating on IBM stock based on eight Buys, five Holds, and two Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average IBM price target of $260.62 per share implies 2.9% downside risk.
